Advertisement

Nervensystem, Auge, Mund, Rachen, Nasennebenhöhlen, Schilddrüse, Thymus, Niere, Nebenniere, Harnblase, Knochen, Weichteile, seltene Tumoren anderer Lokalisation

Chapter
  • 10 Downloads

Zusammenfassung

50% der soliden kindlichen Geschwülste sind Hirntumoren. Sie können — nach histologischen Kriterien — maligne oder benigne sein, wobei histologisch zwar benigne Hirntumoren aufgrund ihrer Lage und chirurgischen Unzugänglichkeit wie Malignome verlaufen können. Mehr als 20% der Hirngeschwülste sind Metastasen extrazerebral gelegener Tumoren. Dabei kommen als Primärlokalisation die Lungen, die Mammae, das Kolon und die Haut (malignes Melanom) in erster Linie in Frage, während andere Primärtumoren nur ausnahmsweise in Betracht gezogen werden müssen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literaturverzeichnis

  1. 236.
    ALBERTO, P., SENN, H.J.: Hormonal therapy of renal carcinoma alone and in association with cytostatic drugs. Cancer (Philad.) 33, 1226 (1974).CrossRefGoogle Scholar
  2. 237.
    BATATA, M.A., MARTINI, N., HUVOS, A.G., AGUILAR, R.I., BEATTIE, E.J.: Thymomas: Clinicopathological features, therapy and prognosis. Cancer (Philad.) 34, 389 (1974).CrossRefGoogle Scholar
  3. 238.
    BERTINO, J.R., MOSHER, M.B., DeCONTI, R.C.: Chemotherapy of cancer of the head and neck. Cancer (Philad.) 31, 1141 (1973).CrossRefGoogle Scholar
  4. 239.
    BLOOM, H.J.G.: Adjuvant therapy for adenocarcinoma of the kidney: Present position and prospects. Brit. J. Urol. 45, 237 (1973).PubMedCrossRefGoogle Scholar
  5. 240.
    BLUM, R.H., CARTER, S.K., AGRE, K.: A clinical review of bleomycin — a new antineoplastic agent. Cancer (Philad.) 31, 903 (1973).CrossRefGoogle Scholar
  6. 241.
    CARTER, S.K., DiMARCO, A., CHIONE, M., KRAKOFF, I.H., MATHé, G. (Eds.): International Symposium on Adriamycin. Berlin-Heidelberg-New York: Springer 1972.Google Scholar
  7. 242.
    CORTES, E.P., HOLLAND, J.F., WANG, J.J., SINKS, L.F., BLOM, J., SENN, H.J., BANK, A., GLIDEWELL, O.: Amputation and adriamycin in primary osteosarcoma. New Engl. J. Med. 291, 998 (1974).PubMedCrossRefGoogle Scholar
  8. 243.
    GOTTLIEB, J.A.: Combination chemotherapy for metastatic sarcoma. Cancer Chemother. Rep. Part 1, 58, 265 (1974).Google Scholar
  9. 244.
    GOTTLIEB, J.A., HILL, C.S.: Chemotherapy of thyroid cancer with adriamycin. New Engl. J. Med. 290, 193 (1974).PubMedCrossRefGoogle Scholar
  10. 245.
    JAFFE, N., FREI, E. III, Traggis, D., Bishop, Y.: Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma. New Engl. J. Med. 291, 994 (1974).PubMedCrossRefGoogle Scholar
  11. 246.
    LEVITT, M., MOSHER, M.B., DeCONTI, R.C., FARBER, L.R., SHEEL, R.T., MARSH, J.C., MITCHELL, M.S., PAPAC, R.J., THOMAS, E.D., BERTINO, J.R.: Improved therapeutic index of methotrexate with ‘leucovorin rescue’. Cancer Res. 33, 1729 (1973).PubMedGoogle Scholar
  12. 247.
    LUBITZ, J.A., FREEMAN, L., OKUN, R.: Mitotane use in inoperable adrenal cortical carcinoma. J. Amer. med. Ass. 223, 1109 (1973).CrossRefGoogle Scholar
  13. 248.
    NAGEL, G.A.: Neuere Zytostatika — Bleomycin und Adriamycin. Ther. Umsch. 30, 657 (1973).PubMedGoogle Scholar
  14. 249.
    NEVIN, J.E., MELNICK, I., BAGGERLY, J.T., HOFFMAN, A., LANDES, R.R., EASLEY, C.: The continuous arterial infusion of 5-fluorouracil as a therapeutic adjunct in the treatment of advanced carcinoma of the bladder and prostate. Cancer (Philad.) 31, 138 (1973).CrossRefGoogle Scholar
  15. 250.
    OWENS, G., JAVID, R., BELMUSTO, L., BENDER, M., BLAU, M.: Intra-arterial vincristine therapy of primary gliomas. Cancer (Philad.) 18, 756 (1965).CrossRefGoogle Scholar
  16. 251.
    PAVONE-MACALUSO, M.: Chemotherapy of vesical and prostatic tumours. Brit. J. Urol. 43, 701 (1971).PubMedCrossRefGoogle Scholar
  17. 252.
    PROUT, G.R., BROSS, I.D.J., SLACK, N.H., AUSMAN, R.K.: Carcinoma of the bladder, 5-fluorouracil and the critical role of a placebo. Cancer (Philad.) 22, 926 (1968).CrossRefGoogle Scholar
  18. 253.
    RUBIN, Ph., MOSTOFI, F.K., BAKER, R., McDONALD, D.F.: Cancer of the urogenital tract: Bladder cancer. Current concepts in cancer (mehrere Artikel). J. Amer. med. Ass. 206, 1761 (1968).CrossRefGoogle Scholar
  19. 254.
    SCHEIN, P.S.: Chemotherapeutic management of the hormone secreting endocrine malignancies. Cancer (Philad.) 30, 1616 (1972).CrossRefGoogle Scholar
  20. 255.
    SIMMONDS, W.P.: Chemotherapy in recurrent head and neck cancer. Otolaryngol. Clin. N. Amer. 7, 205 (1974).Google Scholar
  21. 256.
    SUIT, H.D., RUSSELL, W.O., MARTIN, R.G.: Management of patients with sarcoma of soft tissue in an extremity. Cancer (Philad.) 31, 1247 (1973).CrossRefGoogle Scholar
  22. 257.
    VARMA, V.M., BEIERWALTES, W.H., NOFAL, M.M., NISHIYAMA, R.H., COPP, J.E.: Treatment of thyroid cancer. Death rates after surgery and after surgery followed by sodium Jodide J-131. J. Amer. med. Ass. 214, 1437 (1970).CrossRefGoogle Scholar
  23. 258.
    WOLF, R.L., MENDLOWITZ, M., FRUCHTER, A.: Diagnosis and treatment of pheochromocytoma. Mt. Sinai J. Med. NY 37, 549 (1970).Google Scholar
  24. S. auch: Kapitel 26Google Scholar
  25. Kapitel 27: 309Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1976

Authors and Affiliations

  1. 1.InselspitalBernSchweiz
  2. 2.Kantonsspital Basel, Dept. für Innere Medizin1. Medizinische Universitäts-Klinik, Abt. für OnkologieBaselSchweiz

Personalised recommendations